Alfasigma Denmark ApS

Private limited companyCVR 42447242København ØActive

Alfasigma Denmark ApS is a private limited company, based in København Ø, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2021. Net profit fell 38% from 2024 to 2025, ending at DKK 505k. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 10.7m+12% vs. 2024
Net profitDKK 505k−38% vs. 2024
EquityDKK 4.6m+12.4% vs. 2024
Employees6latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 12% (2024 → 2025), to DKK 10.7m.
  • Net profit fell 38% (2024 → 2025), to DKK 505k.
  • Equity rose 12% (2024 → 2025), to DKK 4.6m.

Employees

  • 1 more employees than a year earlier: 6 (07/2026) against 5 (07/2025).

Management and owners, last 24 months

  • New in management: Line de Linde Henriksen (director, 24/07/2025), Alberto Avaltroni (director, 24/07/2025) and Massimo Giorgio Visentin (director, 31/03/2026) (+1).
  • Stepped down: Michele Manto (director, 31/03/2026), Marcel de Jong (director, 24/07/2025) and Maria Chiara Cucchi (director, 31/03/2026).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 1mDKK 2mDKK 3mDKK 4mDKK 5m20212022202320242025
EquityNet profit
Financial figures for Alfasigma Denmark ApS
20212022202320242025Change
Revenuenot statednot statednot statednot statednot stated–
Gross profit5,08113,80911,7789,53210,681+12%
Operating profit (EBIT)–1,8921,7761,294845−34.7%
Profit before tax5111,8541,7831,051750−28.6%
Net profit3981,4461,390815505−38%
Total assets9,58817,0497,28414,90211,653−21.8%
Equity4381,8843,2744,0894,594+12.4%
Liabilities9,15015,1644,01110,8137,058−34.7%
Cash and cash equivalents3,6040–8340−100%
Average number of employees36645+25%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 2mDKK 4mDKK 6mDKK 8mDKK 10mDKK 12mDKK 14m20212022202320242025
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

5 financial years
Annual reports for Alfasigma Denmark ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202522/07/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202421/07/2025The companyPDFXBRL
202301/01/2023 – 31/12/202323/07/2024The companyPDFXBRL
202201/01/2022 – 31/12/202230/06/2023The companyPDFXBRL
202103/06/2021 – 31/12/202105/07/2022The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0123456708/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 10.7mNo. 119 of 232
Better than 49% of the companies in the industry
EquityDKK 4.6mNo. 146 of 232
Better than 37% of the companies in the industry
Number of employees6No. 134 of 232
Better than 42% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 4,302of 69,742
Better than 94%
No. 14,965of 69,964
Better than 79%
Same industry and fewer than 20 employees150 companies in the comparison
No. 40of 150
Better than 74%
No. 66of 150
Better than 56%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 4,069of 33,588
Better than 88%
No. 6,454of 33,687
Better than 81%
All companies of type ApS66,508 companies in the comparison
No. 5,601of 66,379
Better than 92%
No. 11,944of 66,505
Better than 82%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. Alfasigma Denmark ApSDKK 10.7m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. Alfasigma Denmark ApSDKK 505k
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. Alfasigma Denmark ApSDKK 4.6m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. Alfasigma Denmark ApS6
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Alfasigma Spa100%
Alfasigma Denmark ApS

Management

4 active registrations

Executive management

Executive management at Alfasigma Denmark ApS
NameRoleAppointed
Line de Linde HenriksenDirector24/07/2025
Alberto AvaltroniDirector24/07/2025
Massimo Giorgio VisentinDirector31/03/2026
Alessio BattagliaDirector31/03/2026
Founders
Galapagos NV
Former management (5)
Former management at Alfasigma Denmark ApS
NameRoleAppointedResigned
Bart FiliusDirector03/06/202120/06/2023
Michele MantoDirector03/06/202131/03/2026
Marcel de JongDirector03/06/202124/07/2025
Samara OrsattiDirector31/01/202415/09/2024
Maria Chiara CucchiDirector15/09/202431/03/2026

Signing rule: Selskabet tegnes af en direktør eller af den samlede direktion.

Address and production units

1 active production units

Sundkrogsgade 21
2100 København Ø

København Municipality · Postcode 2100

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
Alfasigma Denmark ApSSundkrogsgade 21, 2100 København Ø61027238161

Purpose

Selskabets formål er at drive virksomhed inden for kommercialisering af farmaceutiske produkter samt aktiviteter, der efter direktionens skøn er forbundet hermed.

The purpose is quoted from the register in Danish.

Changes year by year

25 registered events
20265 changesaccounts 1 · management 4
  • Annual report for 2025 published
  • Alessio Battaglia appointed director
  • Massimo Giorgio Visentin appointed director
  • Maria Chiara Cucchi stepped down as director
  • Michele Manto stepped down as director
20254 changesmanagement 3 · accounts 1
  • Line de Linde Henriksen appointed director
  • Alberto Avaltroni appointed director
  • Marcel de Jong stepped down as director
  • Annual report for 2024 published
20248 changesaddress 1 · name 1 · management 3 · accounts 1 · ownership 2
  • Moved to Sundkrogsgade 21, 2100 København Ø
  • Name changed from Galapagos Biopharma Denmark ApS to Alfasigma Denmark ApS
  • Maria Chiara Cucchi appointed director
  • Samara Orsatti stepped down as director
  • Annual report for 2023 published
  • Samara Orsatti appointed director
  • ALFASIGMA SpA registered as owner (100%)
  • Galapagos NV is no longer registered as owner
20232 changesaccounts 1 · management 1
  • Annual report for 2022 published
  • Bart Filius stepped down as director
20221 changeaccounts 1
  • Annual report for 2021 published
20215 changesfounded 1 · management 3 · ownership 1
  • Registered as Galapagos Biopharma Denmark ApS
  • Bart Filius appointed director
  • Marcel de Jong appointed director
  • Michele Manto appointed director
  • Galapagos NV registered as owner (100%)

Related companies

Same industry in København

See all →

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction